Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
The labral injury is addressed once other disorders are treated or ruled out
BPC-157 is a synthetic 15-amino-acid peptide derived from a Body Protection Compound fragment originally identified in human gastric juice, with research interest in nitric oxide pathway activity, VEGFR2 signalling, and FAK-paxillin pathway involvement
It combines glutathione with Tranexamic Acid, Arbutin, Niacinamide, Kojic Acid, Azelaic Acid, Ferulic Acid, and Encapsulated Retinol
doi: 10.1021/acsnano.4c04901 Summary Keywords diabetic cardiomyopathy, ferroptosis, mitochondrial damage, molecular mechanisms, targeted therapy, combination therapy, clinical applications Citation Liu B, Jin Q, Sun YK, Yang ZM, Meng P, Zhang X, Chen Q, Gan P, Zhao T, He JJ, He GP and Xue Q (2025) From bench to bedside: targeting ferroptosis and mitochondrial damage in the treatment of diabetic cardiomyopathy
Psychiatry 17 (10), 10171025
US$ 22.35
US$ 24.76
US$ 21.85
US$ 27.57
US$ 21.91
US$ 22.08
US$ 26.25
